Andrea Swain Email & Phone Number

Saint Paul, MN, US

Responsible for global strategy, upstream marketing and business development for cardiac pacing therapies business ($2B). Drive cross-functional alignment to secure internal and external investment enabling organizational success to achieving business goals. Co-chair of the Voice pillar of the Medtronic Women's Network (MWN)- MN chapter and MWN Directors.

Responsible for driving development and execution of global reimbursement, health economics and economic value strategies across the cardiac implantables portfolio by guiding prioritization of evidence needs, aligning functional resources to business requirements, securing and managing funding, and ensuring implications of functional strategies are.

Led the Market Access team responsible for creating economic value content for US hospitals across the cardiac implantables portfolio. Managed development and launch of reimbursement and economic tools, messaging, content and collateral in alignment with customer, legal, regulatory and compliance requirements. Partnered across Medtronic to advance the.

Developed and executed launch of three Value-Based Healthcare programs in partnership with functional and regional leaders. Secured internal alignment through cross-functional collaboration, defined program structure and developed messaging, collateral and training material. Built the Market Access function within Economics, Reimbursement and Evidence.

Led pricing governance for the West region, provided recommendations on deal structure, informed pricing decisions and delivered extensive analysis on contracts. Partnered with the field leadership to secure several large contracts each representing +$10M in annual revenue. Aligned product assessment inputs, created pricing model and engaged leadership on.

Responsible for generating and communicating economic data relevant to various stakeholders through driving cross-functional assessment of opportunities, identifying evidence gaps, directing economic research studies and leading economic value commercialization and communication efforts.

Global clinical trial leader for pre-market IPG study. Responsible for global clinical strategy, budget, cross-functional alignment and publications associated with study.Clinical representative on two CRDM core teams responsible for bringing new technologies to the market. Provide insight on clinical, reimbursement and regulatory strategies, outlining.

Managed input from key stakeholders, cross-functional partners and physician advisory committee on post-market to outline study design / objectives and potential risks to ensure desired and achievable study outcomes as well as determine proactive risk mitigation strategies for successful study completion.Wrote and contributed to post-market study documents.

Completed 4 week international assignment to develop database requirements, created training materials, provided training to internatl field support and study center personnel on new device features and study design, and supported international team with start-up activities.Initiated strategy to combine FDA required annual and final reports for a left.

Successfully managed emergency use and compassionate use requests to allow access to unique product.Drove regular trending of deviation data including initiation of corrective and preventative actions to avoid future deviations.Managed data review / cleaning for pariticipating centers and organized closure activities upon study completion.

Minneapolis

Master Of Business Administration (Mba), Business Administration And Management, General

Bachelor Of Science (Bs), Genetics, Cell Biology And Development

Bachelor Of Arts (Ba), Physiology